Metformin therapy in patients with chronic kidney disease

Diabetes, Obesity & Metabolism
J K DuongR O Day

Abstract

Metformin therapy is limited in patients with chronic kidney disease (CKD) due to the potential risk of lactic acidosis. This open-label observational study investigated metformin and lactate concentrations in patients with CKD (n = 22; creatinine clearances 15-40 ml/min) and in two dialysed patients. Patients were prescribed a range of metformin doses (250-2000 mg daily) and metformin concentrations were compared with data from healthy subjects (scaled to 1500 mg twice daily). A subset of patients (n = 7) was controlled on low doses of metformin (250 or 500 mg daily). No correlation between metformin and lactate concentrations was observed. Three patients had high lactate concentrations (>2.7 mmol/l) and two had high metformin concentrations (3-5 mg/l), but none had any symptoms of lactic acidosis. Reducing metformin dosage and monitoring metformin concentrations will allow the safe use of metformin in CKD, provided that renal function is stable.

References

Aug 1, 1981·British Journal of Clinical Pharmacology·G T TuckerH F Woods
Feb 1, 2003·Journal of Pharmaceutical and Biomedical Analysis·A ZarghiA Khoddam
Jun 22, 2005·Clinical Pharmacokinetics·Peter TimminsPunit Marathe
Jul 5, 2007·Clinical Pharmacology and Therapeutics·Y ShuK M Giacomini
Oct 28, 2010·Diabetes, Obesity & Metabolism·K P VasishtG L Bakris
Jan 19, 2011·Clinical Pharmacokinetics·Garry G GrahamKenneth M Williams
Feb 18, 2011·Nephron. Clinical Practice·Helen J Nye, William G Herrington

❮ Previous
Next ❯

Citations

Jun 14, 2013·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Mieczysław Litwin, Anna Niemirska
Jul 20, 2002·European Journal of Medicinal Chemistry·Paola ViciniIrini Doytchinova
Jul 12, 2013·QJM : Monthly Journal of the Association of Physicians·W G HerringtonT Aung
Oct 7, 2014·Canadian Journal of Diabetes·Erik S Venos, Ronald J Sigal
Apr 4, 2013·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Janna K DuongRichard O Day
Mar 7, 2013·Expert Opinion on Drug Metabolism & Toxicology·André J Scheen
Aug 21, 2013·Pharmacoepidemiology and Drug Safety·Farshad KajbafJean-Daniel Lalau
Jun 10, 2014·Diabetic Medicine : a Journal of the British Diabetic Association·W R Adam, R C O'Brien
Jan 11, 2014·Internal Medicine Journal·W HuangG M Peterson
Feb 3, 2015·Transplantation Reviews·Johannes WerzowaManfred Hecking
Nov 26, 2010·International Archives of Medicine·Nada F ZakiWasif S Gillani
Oct 19, 2016·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Felicity C SmithRichard O Day
Oct 1, 2016·Diabetes, Obesity & Metabolism·Tahseen A ChowdhuryM Magdi Yaqoob
Oct 14, 2016·Diabetes, Obesity & Metabolism·Shaun S KumarRichard O Day
Jan 19, 2013·Der Orthopäde·M Schiltenwolf
Sep 18, 2018·Pharmacology Research & Perspectives·Ajith M DissanayakeChristopher J Hood
Jan 22, 2020·Alimentary Pharmacology & Therapeutics·Felicity C SmithRichard O Day
Sep 30, 2016·Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis·Abdullah K Al-HwieshNehad Al-Audah
Apr 9, 2014·Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis·James Heaf
Apr 11, 2015·Critical Care Medicine·Diane P CalelloUNKNOWN Extracorporeal Treatments in Poisoning Workgroup
Feb 16, 2020·British Journal of Clinical Pharmacology·Klarissa A SinnappahDaniel F B Wright
May 1, 2015·Therapeutic Innovation & Regulatory Science·Richard DayNarcyz Ghinea
Jun 24, 2018·Clinical Journal of the American Society of Nephrology : CJASN·Tom N Lea-HenryDarren M Roberts
Jul 25, 2019·BMC Nephrology·Bogdan Marian SorohanCătălin Baston
Jun 16, 2017·Clinical Kidney Journal·Talha H Imam
Aug 3, 2019·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Isabelle H S KuanDaniel F B Wright
Aug 29, 2016·European Journal of Clinical Pharmacology·J MoonR O Day
Jun 11, 2020·British Journal of Clinical Pharmacology·Isabelle H S KuanXiao Zhu
May 20, 2021·Diabetes, Obesity & Metabolism·Jeremy OrloffJames Flory

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.